These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 25064497

  • 1. Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies.
    Suzuki S, Yonekawa T, Kuwana M, Hayashi YK, Okazaki Y, Kawaguchi Y, Suzuki N, Nishino I.
    J Neuroimmunol; 2014 Sep 15; 274(1-2):202-8. PubMed ID: 25064497
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
    Suzuki S, Nishikawa A, Kuwana M, Nishimura H, Watanabe Y, Nakahara J, Hayashi YK, Suzuki N, Nishino I.
    Orphanet J Rare Dis; 2015 May 13; 10():61. PubMed ID: 25963141
    [Abstract] [Full Text] [Related]

  • 3. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
    Benveniste O, Drouot L, Jouen F, Charuel JL, Bloch-Queyrat C, Behin A, Amoura Z, Marie I, Guiguet M, Eymard B, Gilbert D, Tron F, Herson S, Musset L, Boyer O.
    Arthritis Rheum; 2011 Jul 13; 63(7):1961-71. PubMed ID: 21400483
    [Abstract] [Full Text] [Related]

  • 4. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
    Aggarwal R, Oddis CV, Goudeau D, Fertig N, Metes I, Stephens C, Qi Z, Koontz D, Levesque MC.
    Rheumatology (Oxford); 2015 Jul 13; 54(7):1194-9. PubMed ID: 25524922
    [Abstract] [Full Text] [Related]

  • 5. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.
    J Neurol Neurosurg Psychiatry; 2016 Oct 13; 87(10):1038-44. PubMed ID: 27147697
    [Abstract] [Full Text] [Related]

  • 6. [Anti-SRP myopathy: different entity from myositis].
    Suzuki S.
    Rinsho Shinkeigaku; 2012 Oct 13; 52(11):1148-50. PubMed ID: 23196545
    [Abstract] [Full Text] [Related]

  • 7. [Anti-SRP myopathy].
    Suzuki S.
    Rinsho Shinkeigaku; 2011 Nov 13; 51(11):961-3. PubMed ID: 22277439
    [Abstract] [Full Text] [Related]

  • 8. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
    Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV.
    Arthritis Rheum; 2004 Jan 13; 50(1):209-15. PubMed ID: 14730618
    [Abstract] [Full Text] [Related]

  • 9. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.
    Suzuki S, Satoh T, Sato S, Otomo M, Hirayama Y, Sato H, Kawai M, Ishihara T, Suzuki N, Kuwana M.
    Rheumatology (Oxford); 2008 Oct 13; 47(10):1539-42. PubMed ID: 18687709
    [Abstract] [Full Text] [Related]

  • 10. [Anti-signal recognition particle autoantibody positive myopathy].
    Bodoki L, Vincze M, Hortobágyi T, Griger Z, Csonka T, Dankó K.
    Ideggyogy Sz; 2014 Sep 30; 67(9-10):347-53. PubMed ID: 25518264
    [Abstract] [Full Text] [Related]

  • 11. [Autoantibodies of Inflammatory Myopathies: Update].
    Suzuki S.
    Brain Nerve; 2016 Dec 30; 68(12):1443-1451. PubMed ID: 27916754
    [Abstract] [Full Text] [Related]

  • 12. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.
    Hengstman GJ, ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BG.
    Ann Rheum Dis; 2006 Dec 30; 65(12):1635-8. PubMed ID: 16679430
    [Abstract] [Full Text] [Related]

  • 13. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L, Arouche-Delaperche L, Allenbach Y, Benveniste O.
    Curr Rheumatol Rep; 2018 Aug 03; 20(9):56. PubMed ID: 30074107
    [Abstract] [Full Text] [Related]

  • 14. Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
    Miller T, Al-Lozi MT, Lopate G, Pestronk A.
    J Neurol Neurosurg Psychiatry; 2002 Oct 03; 73(4):420-8. PubMed ID: 12235311
    [Abstract] [Full Text] [Related]

  • 15. Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.
    Suzuki S, Uruha A, Suzuki N, Nishino I.
    Autoimmun Rev; 2017 Jul 03; 16(7):693-700. PubMed ID: 28479486
    [Abstract] [Full Text] [Related]

  • 16. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.
    Suzuki S, Hayashi YK, Kuwana M, Tsuburaya R, Suzuki N, Nishino I.
    Arch Neurol; 2012 Jun 03; 69(6):728-32. PubMed ID: 22332183
    [Abstract] [Full Text] [Related]

  • 17. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
    Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L.
    Arthritis Care Res (Hoboken); 2010 Sep 03; 62(9):1328-34. PubMed ID: 20506493
    [Abstract] [Full Text] [Related]

  • 18. [Clinical features and therapeutic response of our anti-SRP positive patients with myositis].
    Botos B, Nagy-Vincze M, Dankó K.
    Orv Hetil; 2017 Sep 03; 158(35):1382-1389. PubMed ID: 28847176
    [Abstract] [Full Text] [Related]

  • 19. Skeletal Muscle Involvement in Antisynthetase Syndrome.
    Noguchi E, Uruha A, Suzuki S, Hamanaka K, Ohnuki Y, Tsugawa J, Watanabe Y, Nakahara J, Shiina T, Suzuki N, Nishino I.
    JAMA Neurol; 2017 Aug 01; 74(8):992-999. PubMed ID: 28586844
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
    Picard C, Vincent T, Lega JC, Hue S, Fortenfant F, Lakomy D, Humbel RL, Goetz J, Molinari N, Bardin N, Bertin D, Johanet C, Chretien P, Dubucquoi S, Streichenberger N, Desplat-Jégo S, Bossuyt X, Sibilia J, Abreu I, Chevailler A, Fabien N.
    Immunol Res; 2016 Jun 01; 64(3):677-86. PubMed ID: 26744256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.